Evoke Pharma Price to Book Ratio 2012-2024 | EVOK
Historical price to book ratio values for Evoke Pharma (EVOK) over the last 10 years. The current price to book ratio for Evoke Pharma as of November 01, 2024 is 1.56.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Evoke Pharma Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2024-11-01 |
5.80 |
|
1.60 |
| 2024-06-30 |
6.35 |
$3.63 |
1.75 |
| 2024-03-31 |
7.32 |
$4.88 |
1.50 |
| 2023-12-31 |
12.60 |
$-9.25 |
-1.36 |
| 2023-09-30 |
16.56 |
$-3.14 |
-5.28 |
| 2023-06-30 |
19.80 |
$1.93 |
10.24 |
| 2023-03-31 |
22.80 |
$7.64 |
2.99 |
| 2022-12-31 |
32.16 |
$14.67 |
2.19 |
| 2022-09-30 |
22.44 |
$19.87 |
1.13 |
| 2022-06-30 |
38.88 |
$25.82 |
1.51 |
| 2022-03-31 |
71.28 |
$8.47 |
8.42 |
| 2021-12-31 |
79.20 |
$15.68 |
5.05 |
| 2021-09-30 |
187.20 |
$21.07 |
8.89 |
| 2021-06-30 |
197.28 |
$26.50 |
7.44 |
| 2021-03-31 |
263.52 |
$34.78 |
7.58 |
| 2020-12-31 |
371.52 |
$-17.40 |
-21.35 |
| 2020-09-30 |
675.36 |
$-10.53 |
-64.16 |
| 2020-06-30 |
509.76 |
$-2.07 |
-246.21 |
| 2020-03-31 |
167.04 |
$17.22 |
9.70 |
| 2019-12-31 |
233.28 |
$25.84 |
9.03 |
| 2019-09-30 |
123.84 |
$30.77 |
4.03 |
| 2019-06-30 |
90.00 |
$37.93 |
2.37 |
| 2019-03-31 |
216.00 |
$24.79 |
8.71 |
| 2018-12-31 |
357.12 |
$33.29 |
10.73 |
| 2018-09-30 |
429.12 |
$44.72 |
9.60 |
| 2018-06-30 |
360.00 |
$45.71 |
7.88 |
| 2018-03-31 |
299.52 |
$40.34 |
7.43 |
| 2017-12-31 |
325.44 |
$20.25 |
16.07 |
| 2017-09-30 |
480.96 |
$19.26 |
24.98 |
| 2017-06-30 |
368.44 |
$63.40 |
5.81 |
| 2017-03-31 |
446.40 |
$74.30 |
6.01 |
| 2016-12-31 |
290.88 |
$44.20 |
6.58 |
| 2016-09-30 |
325.44 |
$54.88 |
5.93 |
| 2016-06-30 |
986.40 |
$-30.18 |
-32.69 |
| 2016-03-31 |
732.96 |
$15.08 |
48.60 |
| 2015-12-31 |
475.20 |
$69.33 |
6.85 |
| 2015-09-30 |
419.04 |
$107.95 |
3.88 |
| 2015-06-30 |
753.12 |
$98.54 |
7.64 |
| 2015-03-31 |
1015.20 |
$149.56 |
6.79 |
| 2014-12-31 |
849.60 |
$216.66 |
3.92 |
| 2014-09-30 |
791.93 |
$275.66 |
2.87 |
| 2014-06-30 |
1164.96 |
$358.38 |
3.25 |
| 2014-03-31 |
1206.72 |
$435.92 |
2.77 |
| 2013-12-31 |
1072.80 |
$500.71 |
2.14 |
| 2013-09-30 |
1753.92 |
$479.12 |
3.66 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.005B |
$0.005B |
|
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
|
